These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10605463)

  • 1. [Nosocomial infections].
    Joly-Guillou ML
    Presse Med; 1999 Nov; 28 Suppl 3():17-8. PubMed ID: 10605463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use.
    Garrouste-Orgeas M; Timsit JF; Kallel H; Ben Ali A; Dumay MF; Paoli B; Misset B; Carlet J
    Infect Control Hosp Epidemiol; 2001 Nov; 22(11):687-92. PubMed ID: 11842988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Do glycopeptides remain the preferred treatment of nosocomial infections from multidrug resistant Staphylococcus?].
    Brun-Buisson C
    Med Mal Infect; 2004 Sep; 34 Suppl 2():S184-7. PubMed ID: 15620801
    [No Abstract]   [Full Text] [Related]  

  • 4. Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen.
    Martin MA
    Curr Clin Top Infect Dis; 1994; 14():170-91. PubMed ID: 8086114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms.
    Henderson DK
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S46-54: discussion S64-73. PubMed ID: 16813982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance of community and hospital acquired Staphylococcus aureus isolates to oxacillin and glycopeptides.
    Anwar MS; Bokhari SR
    J Coll Physicians Surg Pak; 2003 Jan; 13(1):33-6. PubMed ID: 12685973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRSA and MRSE: is there an answer?
    Carbon C
    Clin Microbiol Infect; 2000 Aug; 6 Suppl 2():17-22. PubMed ID: 11523520
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models.
    Austin DJ; Anderson RM
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):721-38. PubMed ID: 10365398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Appelbaum PC
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():16-23. PubMed ID: 16445720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycopeptides in the treatment of staphylococcal infections.
    Daschner FD; Kropec A
    Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S12-7. PubMed ID: 7729466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nasal carriage of meticillin-resistant Staphylococcus aureus among health care personnel in Abidjan (Côte d'lvoire)].
    Akoua Koffi C; Dje K; Toure R; Guessennd N; Acho B; Faye Kette H; Loukou YG; Dosso M
    Dakar Med; 2004; 49(1):70-4. PubMed ID: 15782482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Profile of patients facing therapeutic problems in nosocomial infections due to methicillin-resistant staphylococci--A survey of practices].
    Sollet JP; Gauzit R
    Ann Fr Anesth Reanim; 2002 May; 21(5):410-3. PubMed ID: 12078435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci.
    Bergeret M; Boutros N; Raymond J
    Int J Antimicrob Agents; 2004 Mar; 23(3):247-53. PubMed ID: 15164965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who's winning the war?
    Gould IM
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii3-6. PubMed ID: 18829723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRSA: Pandora's box for hospitals.
    Shovein J; Young MS
    Am J Nurs; 1992 Feb; 92(2):48-52. PubMed ID: 1739114
    [No Abstract]   [Full Text] [Related]  

  • 18. [Searching for Staphylococcus aureus strains with reduced susceptibility to glycopeptides among clinical isolates obtained during the year of 2002].
    Młynarczyk A; Młynarczyk G; Łuczak M
    Med Dosw Mikrobiol; 2003; 55(3):209-17. PubMed ID: 14702662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for gram-positive nosocomial sepsis.
    Wood MJ
    J Chemother; 1999 Dec; 11(6):446-52. PubMed ID: 10678786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methicillin-resistant Staphylococcus colonization. Impact on morbidity, mortality, and glycopeptide use].
    Garrouste-Orgeas F
    Presse Med; 2001 Feb; 30(7):333-4. PubMed ID: 11262809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.